C4 Therapeutics CCCC
NASDAQ CCCC
$3.15 -0.02 (-0.63%)
As of: Oct 22, 2026 · 9:45 AM EDT

C4 Therapeutics (CCCC) Total Non-Current Liabilities (2020)

Updated

C4 Therapeutics (CCCC) reported Total Non-Current Liabilities of $379.59 million for Q3 2020.

Analysis

C4 Therapeutics (CCCC) Total Non-Current Liabilities (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,155.80 Bn 1,124.39 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 630.65 Bn 549.18 Bn 17.26 Bn 105.50 Bn
3 AbbVie 502.74 Bn 475.85 Bn 12.70 Bn 106.45 Bn
4 Merck 375.34 Bn 329.72 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 301.36 Bn 265.35 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 265.02 Bn 238.70 Bn 12.86 Bn 33.91 Bn
7 Amgen 239.16 Bn 194.55 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 192.63 Bn 166.82 Bn 6.22 Bn 35.10 Bn
9 Pfizer 171.82 Bn 118.47 Bn 10.94 Bn 97.04 Bn
10 C4 Therapeutics 413.00 Mn -516.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 379.59 Mn
API Access

C4 Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CCCC&period=max&api_key=YOUR_API_KEY